The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Claim of first human stem cell trial unravels

| October 15, 2012
Claims by a Japanese scientist to have run a clinical trial in which reprogrammed cardiac muscle cells grown from induced pluripotent stem cells were transplanted into six US patients with severe heart failure were apparently inflated or made up.
View the original article here: Claim of first human stem cell trial unravels

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend